XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,000 | -28.6% | 14,205 | +19.1% | 0.00% | – |
| Q2 2021 | $49,000 | -46.7% | 11,925 | -41.7% | 0.00% | – |
| Q1 2021 | $92,000 | +5.7% | 20,464 | +15.3% | 0.00% | – |
| Q4 2020 | $87,000 | +11.5% | 17,741 | +35.5% | 0.00% | – |
| Q3 2020 | $78,000 | +169.0% | 13,090 | +18.1% | 0.00% | – |
| Q2 2020 | $29,000 | -71.6% | 11,080 | +7.1% | 0.00% | -100.0% |
| Q3 2019 | $102,000 | -11.3% | 10,344 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $115,000 | +0.9% | 10,030 | -11.4% | 0.00% | 0.0% |
| Q1 2019 | $114,000 | – | 11,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|